Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Psychiatry Division To Be Headed By Laughren Under Restructuring Plan

This article was originally published in The Pink Sheet Daily

Executive Summary

Neuropharmacological reviewer Laughren will head FDA's psychiatric drug reviews after the division is spun off under the Office of New Drugs reorganization. Laughren's appointment is one of few top-level promotions under the restructuring effort.

You may also be interested in...

CDER’s Neurology Division Prepares For New Leadership With Director Katz’s Retirement

Russell Katz will retire following a 30-year career at FDA; his departure comes as the agency is embarking on new efforts to encourage drug development for Alzheimer’s disease and amyotrophic lateral sclerosis.

FDA Gastroenterology Drugs Division Headed By Harvey; Phase-Out Of ODE V Complete

Harvey brings GI experience from the device center as former Gastroenterology & Renal Devices Branch reviewer. His appointment comes as FDA is eliminating the Office of Drug Evaluation V under the reorganization of the Office of New Drugs.

FDA Reorganization Of New Drug Office Would Split Neuropharmaceutical Division

Neurology and psychiatry drugs would be reviewed in separate divisions under the proposed restructuring. The reorganization, which aims to group products by therapeutic indications and integrate the review of biologics and drugs, would eliminate ODE V.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts